Health X Platform Board of Directors

Get the latest insights into the leadership at Health X Platform. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Banwari Lal Mittal Chairman & Managing Director
Mrs. Abha Mittal Non Executive Director
Mr. Ravi Kant Sharma Non Executive Director
Mrs. Rupanjana De Independent Director
Dr. J N Mukhopadhyaya Independent Director
Mrs. Anjana Dikshit Independent Director

Health X Platform Share price

SASTASUNDR

283.15

6.90 (2.50%)
NSE
BSE
Last updated on 17 Mar, 2026 | 14:05 IST
Today's High

283.85

Today's Low

274.80

52 Week Low

230.00

52 Week High

363.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Health X Platform FAQs

The board at Health X Platform consists of experienced professionals, including Mr. Banwari Lal Mittal , Mrs. Abha Mittal , and others, overseeing the company’s strategic and corporate governance.

Directors at Health X Platform are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Banwari Lal Mittal is the current chairman at Health X Platform.

Executive directors at Health X Platform are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Health X Platform adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Health X Platform, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost